2025 annual financial data
Arcutis Biotherapeutics 2025 Operating margin
Arcutis Biotherapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -3.25%.
Operating income was -12,227,000 USD and net income was -16,140,999 USD.
Operating cash flow was -5,625,000 USD.
Get free Arcutis Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 376,072,000 USD
- Operating income
- -12,227,000 USD
- Net income
- -16,140,999 USD
- Operating cash flow
- -5,625,000 USD